Document Type : Original Article

Authors

1 Non-communicable Diseases Research Center, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran

2 Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran

3 Research Center for Social Determinants of Health, Jahrom University of Medical Sciences, Jahrom, Iran

4 Health Affairs, Shiraz University of Medical Sciences, Shiraz, Iran

5 Non-communicable Diseases Research Center, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran

6 Research Center for Health Sciences, Institute of Health, Department of Epidemiology, Shiraz University of Medical Sciences, Shiraz, Iran

7 Technical Deputy of Vice-chancellery for Health, Shiraz University of Medical Sciences, Shiraz, Iran

8 Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

9 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

10 Department of Health Education and Health Promotion, School of Health, Medical Education Research Center, Health Management and Safety Promotion Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran

Abstract

Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be transmitted through direct, indirect, or close contact with infected people by contaminated respiratory droplets or saliva. This study aimed to investigate the epidemiology of coronavirus disease 2019 (COVID-19) and the secondary attack rate (SAR) in the cases’ close contact.
Methods: A total of 431 confirmed COVID-19 patients were randomly selected using systematic random sampling from 15 May to 13 June 2020. The required data were extracted from the CORONALAB database of the Center for Disease Control and Prevention (CDC) at Shiraz University of Medical Sciences. Detection of COVID-19 was performed using Real- Time Polymerase Chain Reaction (RT-PCR) and nasopharyngeal swabs. SAR was also calculated for different groups.
Results: Among the index cases, 64.27% were male, 24.80% were public sector employees, and 4.87% were admitted to the intensive care unit. In addition, most of them aged 30-39 years. The SAR was 11.56% (95% CI: 9.86% to 13.25%) in the close contacts. Accordingly, the highest SAR was observed among the friends, 19.05% (95% CI: 7.17% to 30.92%), followed by the spouses of COVID-19 cases, 16.67% (95% CI: 10.81% to 22.51%). Furthermore, diabetes (6.03%) and cardiovascular disease (5.1%) were the most common comorbidities among the index cases.
Conclusion: The findings suggested that the SAR was relatively lower among the close contacts. Considering the familial and non-familial relationships between the index cases and their close contacts were the major causes of disease transmission. Therefore, it is crucial to conduct tracing for COVID-19 contacts in all cases with whom patients have had close contact.

Keywords

  1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet. 2020;395(10224):565-74. doi: 10.1016/S0140-6736(20)30251-8. PMID: 32007145.
  2. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2020.
  3. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England journal of medicine. 2020;382(10):970-1. doi: 10.1056/NEJMc2001468.
  4. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of travel medicine. 2020. doi: 10.1093/jtm/taaa021. PMID: 32052846.
  5. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England journal of medicine. 2020;382(12):1177-9. doi: 10.1056/NEJMc2001737.
  6. Heymann DL, Shindo N. COVID-19: what is next for public health? The lancet. 2020;395(10224):542-5. doi: 10.1016/S0140-6736(20)30374-3.
  7. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The lancet. 2020;395(10223):514-23. doi: 10.1016/S0140-6736(20)30154-9.
  8. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature. 2020;579(7798):270-3. doi: 10.1038/s41586-020-2012-7.
  9. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. The Lancet infectious diseases. 2020;20(8):911-9. doi: 10.1016/S1473-3099(20)30287-5. PMID: 32353347.
  10. Patel A, Jernigan DB, Abdirizak F, Abedi G, Aggarwal S, Albina D, et al. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, 31 December, 2019–4 February, 2020. Morbidity and mortality weekly report. 2020;69(5):140. doi: 10.15585/mmwr.mm6905e1. PMID: 32027631.
  11. She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clinical and translational medicine. 2020;9(1):1-7. doi: 0.1186/s40169-020-00271-z. PMID: 32078069.
  12. Liu J, Liao X, Qian S, Yuan J, Wang F, Liu Y, et al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerging infectious diseases. 2020;26(6):1320. doi: 10.3201/eid2606.200239. PMID: 32125269.
  13. Center for disease control and prevention. https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/contact-tracing.html.
  14. Mirahmadizadeh A, Ghelichi-Ghojogh M, Vali M, Jokari K, Ghaem H, Hemmati A, et al. Correlation between human development index and its components with COVID-19 indices: a global level ecologic study. BMC Public Health. 2022;22(1):1-8. doi: 10.1186/s12889-022-13698-5. PMID: 35971079.
  15. Hasanzadeh J, Rezaei F, Mirahmadizadeh A. Estimation of the Reproductive Number Trend of the Novel Coronavirus” COVID-19 “in Southern Iran from July to November 2020. Iranian Journal of Medical Sciences. 2022. doi: 10.30476/IJMS.2021.90333.2118. PMID: 35919079.
  16. Mirahmadizadeh A, Rezaei F, Jokari K, Moftakhar L, Hemmati A, Dehghani SS, et al. Correlation between environmental factors and COVID-19 indices: a global level ecological study. Environmental Science and Pollution Research. 2022;29(11):16667-77. doi: 10.1007/s11356-021-16876-x. PMID: 34651278.
  17. Rezaei F, Ghelichi-Ghojogh M, Hemmati A, Ghaem H, Mirahmadizadeh A. Risk factors for COVID-19 severity and mortality among inpatients in Southern Iran. Journal of Preventive Medicine and Hygiene. 2021;62(4):E808. doi: 10.15167/2421-4248/jpmh2021.62.4.2130. PMID: 35603242.
  18. Jing Q-L, Liu M-J, Zhang Z-B, Fang L-Q, Yuan J, Zhang A-R, et al. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. The Lancet Infectious Diseases. 2020;20(10):1141-50. doi: 10.1016/S1473-3099(20)30471-0. PMID: 32562601.
  19. Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt T, Holshue M, et al. Active monitoring of persons exposed to patients with confirmed COVID-19—United States, January–February 2020. Morbidity and Mortality Weekly Report. 2020;69(9):245. doi: 10.15585/mmwr.mm6909e1. PMID: 32134909.
  20. Luo L, Liu D, Liao X, Wu X, Jing Q, Zheng J, et al. Contact settings and risk for transmission in 3410 close contacts of patients with COVID-19 in Guangzhou, China: a prospective cohort study. Annals of internal medicine. 2020;173(11):879-87. doi: 10.7326/M20-2671. PMID: 32790510.
  21. Davies NG, Klepac P, Liu Y, Prem K, Jit M, Eggo RM. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nature medicine. 2020;26(8):1205-11.
  22. International Migration Report. United Nations. 2016.
  23. Molaee Zadeh M, Shahandeh K, Bigdeli S, Basseri HR. Conflict in neighboring countries, a great risk for malaria elimination in Southwestern Iran: narrative review article. Iranian Journal of Public Health. 2014;43(12):1627. PMID: 26171354.
  24. Behzadi MA, Ziyaeyan M, Asaei S. Hepatitis B virus DNA level among the seropositive Afghan immigrants, southern Iran. Jundishapur journal of microbiology. 2014;7(5). doi: 10.5812/jjm.10127. PMID: 25147713.
  25. Moradi M, Arababadi MK, Hassanshahi G. Tuberculosis in the Afghan immigrant in Kerman province of Iran. Journal of Biological Sciences. 2008;8(6):1107-9.
  26. Hajia M, Rahbar M, Rahnamye Farzami M, Masoumi Asl H, Dolatyar A, Imani M, et al. Assessing clonal correlation of epidemic Vibrio cholerae isolates during 2011 in 16 provinces of Iran. Current microbiology. 2015;70(3):408-14. doi: 10.1007/s00284-014-0725-2.
  27. Alavi-Naini R, Moghtaderi A, Koohpayeh H-R, Sharifi-Mood B, Naderi M, Metanat M, et al. Crimean-Congo hemorrhagic fever in Southeast of Iran. Journal of Infection. 2006;52(5):378-82. doi: 10.1016/j.jinf.2005.07.015.
  28. Rivett L, Sridhar S, Sparkes D, Routledge M, Jones NK, Forrest S, et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. elife. 2020;9:e58728. doi: 10.7554/eLife.58728. PMID: 32392129.
  29. Arnedo-Pena A, Sabater-Vidal S, Meseguer-Ferrer N, Pac-Sa MR, Mañes-Flor P, Gascó-Laborda JC, et al. COVID-19 secondary attack rate and risk factors in household contacts in Castellon (Spain): Preliminary report. Enfermedades Emergentes. 2020;19(2):64-70.
  30. Liu T, Liang W, Zhong H, He J, Chen Z, He G, et al. Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing. Emerging microbes & infections. 2020;9(1):1546-53. doi: 10.1080/22221751.2020.1787799. PMID: 32608325.
  31. Xin H, Jiang F, Xue A, Liang J, Zhang J, Yang F, et al. Risk factors associated with occurrence of COVID‐19 among household persons exposed to patients with confirmed COVID‐19 in Qingdao Municipal, China. Transboundary and Emerging Diseases. 2021;68(2):782-8. doi: 10.1111/tbed.13743. PMID: 32688447.
  32. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID‐19. Diabetes/metabolism research and reviews. 2020;36(7):e3319. doi: 10.1002/dmrr.3319.
  33. Zaki N, Alashwal H, Ibrahim S. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(5):1133-42. doi: 10.1016/j.dsx.2020.07.005. PMID: 32663789.